Bioavailability and absorption kinetics of nicotine following application of a transdermal system
- PMID: 9114908
- PMCID: PMC1364642
- DOI: 10.1111/j.1365-2125.1993.tb04221.x
Bioavailability and absorption kinetics of nicotine following application of a transdermal system
Abstract
1. The absolute bioavailability and absorption kinetics of nicotine were investigated in 13 healthy adult male smokers following single and multiple applications of a nicotine transdermal system (NTS), designed to release nicotine at an approximate rate of 1.5 mg h-1 over 24 h. The absorption of nicotine from the single NTS application was calculated with reference to a simultaneous intravenous infusion (i.v.) of deuterium-labelled nicotine. 2. The mean input time (MIT) and mean absorption time (MAT) for nicotine following application of NTS for 24 h were 7.7 and 4.2 h, respectively. 3. Following NTS removal, the mean apparent nicotine elimination half-life was 2.8 h, compared with 2.0 h following i.v. nicotine, reflecting continued absorption of nicotine following NTS removal. 4. The mean amount of nicotine absorbed from the NTS after the 24 h application was 20.9 mg, which represents about 68% of the amount released from the system; the remaining 32% was lost from the system during daily activities. 5. The ratio of AUC values for the metabolite cotinine relative to nicotine was similar whether nicotine was administered transdermally or intravenously. 6. Following i.v. administration, the mean nicotine clearance was 72 l h-1 (coefficient of variation 29%). Since coefficients of variation in AUC values following NTS and i.v. treatments were similar, transdermal administration of nicotine was not associated with increased interindividual variability in plasma nicotine concentrations. 7. No significant changes were seen in the pharmacokinetics of nicotine between single and multiple applications of NTS. 8. As expected from the higher total plasma nicotine concentrations, the incidence of adverse effects was higher following simultaneous intravenous and transdermal administration of nicotine. The most frequently reported systemic side effects were nervousness and headache: mild itching was the most frequent topical effect.
Similar articles
-
Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.J Clin Pharmacol. 1995 Oct;35(10):985-9. doi: 10.1002/j.1552-4604.1995.tb04014.x. J Clin Pharmacol. 1995. PMID: 8568016 Clinical Trial.
-
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).J Clin Pharmacol. 1993 Feb;33(2):169-74. doi: 10.1002/j.1552-4604.1993.tb03939.x. J Clin Pharmacol. 1993. PMID: 8440767 Clinical Trial.
-
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.Br J Clin Pharmacol. 1997 Mar;43(3):259-67. doi: 10.1111/j.1365-2125.1997.00566.x. Br J Clin Pharmacol. 1997. PMID: 9088580 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of nicotine.Clin Pharmacokinet. 1987 Jan;12(1):30-40. doi: 10.2165/00003088-198712010-00003. Clin Pharmacokinet. 1987. PMID: 3545615 Review.
-
The local side effects of transdermally absorbed nicotine.Skin Pharmacol. 1992;5(2):69-76. doi: 10.1159/000211021. Skin Pharmacol. 1992. PMID: 1637561 Review.
Cited by
-
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.Psychopharmacology (Berl). 2020 Jan;237(1):219-230. doi: 10.1007/s00213-019-05363-4. Epub 2019 Nov 4. Psychopharmacology (Berl). 2020. PMID: 31686175 Free PMC article.
-
Transdermal Nicotine Poisoning: A Rare Case Report of Occupational Exposure.Toxics. 2023 May 17;11(5):464. doi: 10.3390/toxics11050464. Toxics. 2023. PMID: 37235278 Free PMC article.
-
Higher blood nicotine concentrations following smokeless tobacco (pituri) and cigarette use linked to adverse pregnancy outcomes for Central Australian Aboriginal pregnancies.BMC Public Health. 2022 Nov 23;22(1):2157. doi: 10.1186/s12889-022-14609-4. BMC Public Health. 2022. PMID: 36419022 Free PMC article.
-
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration.Psychopharmacology (Berl). 2008 Feb;196(2):189-200. doi: 10.1007/s00213-007-0952-3. Epub 2007 Oct 3. Psychopharmacology (Berl). 2008. PMID: 17912500 Free PMC article. Clinical Trial.
-
Transcutaneous nicotine does not prevent postoperative nausea and vomiting: a randomized controlled trial.Br J Clin Pharmacol. 2011 Mar;71(3):383-90. doi: 10.1111/j.1365-2125.2010.03844.x. Br J Clin Pharmacol. 2011. PMID: 21284697 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials